STAT

The opportunity ‘is huge’: Why tech developers are trying to tackle mental health

Pills with digital sensors. Virtual reality worlds to treat addiction. Therapy chatbots. Tech is taking on mental health.

SAN FRANCISCO — Here in the technology epicenter of the world, developers are increasingly writing code and launching products to try to disrupt yet another field: mental health.

Even as big tech players have conquered the markets in industries like transportation and lodging, they’ve largely steered clear of mental health treatment. Now, however, with an influx of funding, companies are revamping pills with digital sensors, designing virtual reality worlds to treat addiction and other conditions, and building chatbots for interactive therapy.

The excitement in the, a day of TED-Talk-style speeches that felt much like any of the other hackathons and demo days that clutter the calendar here. The venue was scattered with signs that trumpeted the event’s unusual mission: “Inspiring developers to build for mental health.”

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks